维普中文期刊产品整合服务
37篇 您的检索式:作者名="Lablanche JM"
    题名 作者 年代 出处 被引量
1Relation to restenosis after PTCA显示文摘Bertrand ME Lablanche JM Fourrier JL 1989Am J Cardiol1989,63,:1
2Factors predictive of resten osis after st en t implantation managed by tic lo pidine and aspirin显示文摘lablanche JM Danchin N Grollier G 1996Circul at ion1996,94,:1
3Comparison of the effi- cacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/ apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study显示文摘Lablanche JM Leone A Merkely B 2010Arch Cardiovasc Dis2010,103,3:1
4Effects of rosuvastatinand atorvastatin on the apolipoprotein B/apolipoprotein A-l ratioin patients with an acute coronary syndrome:The CENTAURUStrial design显示文摘Lablanche JM Danchin N’Farnier M 2008Arch Cardiovasc Dis2008,101,6:1
5Frequency of proyoked coronary arterial spasm in 1089 comsecutive patients undergoing coronary显示文摘Bertrand ME Lablanche JM Tihnant Py 1982Arteriography1982,65,:1
6Percutaneous translum inal coronary artery ablation with rotablator(European experience)显示文摘Bertrand M E Lablanche JM Leroy F 1992Am J cardio1992,69,:1
7Results of prevention of Restenosis with tranilast and its outcomes (PRESTO) trial显示文摘Holmes DR Savage M LaBlanche JM 2002Circulation2002,106,10:1
8Comparison of the efficacy of rosuvastatin versus atorvastatin in reduc- ing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the centaurus study显示文摘Lablanche JM Leone A Merkely B 2010Arch Cardiovasc Dis2010,103,3:1
9Effects of rosuvastatin and atorvastatin on the apollpoprotein βapolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS triai design 显示文摘Lablanche JM Danchin N Farnier M et aI 2008Arch Cardiovase DIS2008,101,6:1
10Results of prevention of restenosis with tranilast and its outcomes(PRESTO) trial 显示文摘Holmes DR J Savage M LaBlanche JM 2002Circulation2002,106,:1
11Effects of rcsuvastatin and atorvastatin on the apolipopretein B/apolipoprotein A-1 ratio in pa- tients with an acute coronary syndrome:The CENTAURUS trial design 显示文摘Lablanche JM Danehin N Farnier M 2008Arch Cardiovasc Dis2008,101,6:1
12Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome:The CENTAURUS trial design 显示文摘Lablanche JM Danchin N Farnier M 2008Arch Cardiovasc Dis2008,101,6:1
13Risk factors for stem thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients:the EVASTENT Matched-Cohort显示文摘Machecourt J Danchin N Lablanche JM 2007J Am Coll Cardiol2007,50,6:1
14Riskfactors for stent thrombosis after implantation ofsirolimus-eluting stents in diabetic and nondiabeticpatients: the EVASTENT matched-cohort registry 显示文摘Machecourt J Danchin N Lablanche JM 2007JAm Coll Cardiol2007,50,6:1
15Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the centaurus study 显示文摘Lablanche JM Leone A Merkely B 2010Arch Cardiovasc Dis2010,103,3:1
16Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography显示文摘Bertrand ME LaBlanche JM Tilmant PY 1982Circulation1982,65,7:1
17Effect of nadroparin,a low-molecular-weight heparin,on clinical and angiographic restenosis after coronary balloon angioplasty显示文摘Lablanche JM McFadden EP Meneveau N 1997Circulation1997,96,:1
18Response of human coronary aeteries to serotonin after injury by coronary angioplasty显示文摘Mc Fadden EP Bauters C Lablanche JM 1993Circulation1993,88,:1
19Factors predictive of restenosis after stent implentation managed by ticlopidine and aspirin显示文摘Lablanche JM Danchin N Grollier 1996Circulation1996,94,:1
20Factors predictive of restenosis after stent implantation managed by tielopidine and aspirin显示文摘Lablanche JM Danchin N Grollier 1996Circulation1996,94,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费